NKI-1

N/A

Report date: 2025/01/26 16:44:41
NME

Base Information

Drug NameNKI-1
Drug Alias NameNADK inhibitor (Institut Pasteur/Universite de Montpellier/Institut Curie)NKI-1
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionNAD(Nicotinamide adenine dinucleotide) inhibitors
TargetsNAD(Nicotinamide adenine dinucleotide)
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitut Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of MontpellierInstitut CurieInstitut Pasteur
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A